Stockreport

United Therapeutics Stock Soars on Strong Phase 3 Lung Disease Results [Yahoo! Finance]

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations
PDF United Therapeutics ( NASDAQ:UTHR ) surged 14% on Monday after the company reported positive Phase 3 results for nebulized Tyvaso in treating idiopathic pulmonary fibro [Read more]